Noah Goodman

Companies

• Kymera TherapeuticsChief Business Officer Apr 9, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKymera Therapeutics KYMR47,179 shares²$5.1M at $108.14Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Sold 3,389 shares at $114.29 of Kymera Therapeutics²
• Jun 25, 2026Sold 2,500 shares at $119.00 of Kymera Therapeutics³
• Jun 25, 2026Sold 2,500 shares at $109.00 of Kymera Therapeutics³
• Jun 25, 2026Exercised options 5,000 shares at $21.05 of Kymera Therapeutics³
• Jun 22, 2026Sold 2,500 shares at $99.00 of Kymera Therapeutics⁴
• Jun 22, 2026Exercised options 2,500 shares at $21.05 of Kymera Therapeutics⁴
• Apr 14, 2026Sold 1,347 shares at $90.00 of Kymera Therapeutics⁵
• Apr 10, 2026Sold 2,000 shares at $87.35 of Kymera Therapeutics⁶
• Apr 9, 2026Sold 2,500 shares at $89.00 of Kymera Therapeutics⁶
• Apr 9, 2026Sold 2,670 shares at $87.11 of Kymera Therapeutics⁶
• Apr 9, 2026Sold 3,094 shares at $86.62 of Kymera Therapeutics⁶
• Apr 9, 2026Exercised options 2,500 shares at $21.05 of Kymera Therapeutics⁶
• Mar 2, 2026Granted 9,225 shares of Kymera Therapeutics⁷
• Apr 8, 2025Granted 50,000 shares of Kymera Therapeutics⁸